These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7019300)

  • 21. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
    Fisher B; Jeong JH; Anderson S; Wolmark N
    J Natl Cancer Inst; 2004 Dec; 96(24):1823-31. PubMed ID: 15601638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The results of 5 years of ancillary chemotherapy of carcinoma of the breast (author's transl)].
    von Maillot K; Egger H; Gunselmann W
    Geburtshilfe Frauenheilkd; 1981 Jul; 41(7):461-4. PubMed ID: 7021305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
    Taucher S; Steger GG; Jakesz R; Tausch C; Wette V; Schippinger W; Kwasny W; Reiner G; Greil R; Dubsky P; Poestlberger S; Tschmelitsch J; Samonigg H; Gnant M;
    Breast Cancer Res Treat; 2008 Nov; 112(2):309-16. PubMed ID: 18080748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G; Kratzer H; Denz H; Huber H
    Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
    Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
    Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.
    Bellon JR; Shulman LN; Come SE; Li X; Gelman RS; Silver BJ; Harris JR; Recht A
    Cancer; 2004 Apr; 100(7):1358-64. PubMed ID: 15042668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Initial immunochemotherapy in inflammatory carcinomas of the breast. Preliminary results of a trials in 9 patients (author's transl)].
    Zylberberg B; Amiel JP; Jamain B; Pouillart P; Ravina JH; Salat-Baroux J
    Nouv Presse Med; 1979 Mar; 8(10):755-8. PubMed ID: 379807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Conservative treatment of breast carcinoma with or without prophylactic chemotherapy. Preliminary results in 45 cases (author's transl)].
    Bolla M; Rouach D; Kolodie H; Vincent F; Gabelle P; Swiercz P; Vrousos C
    Sem Hop; 1982 Apr; 58(15):909-12. PubMed ID: 6281906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long survival periods after therapy for metastatic or reccurrent cancer (author's transl)].
    Israel L; Depierre A
    Sem Hop; 1978 Dec 8-15; 54(43-44):1382-4. PubMed ID: 219495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arterial chemotherapy of tumors. Considerations on 159 cases].
    Caldarola L; Badellino F; Canavese G; Volterrani P; Giani R
    Minerva Chir; 1978 Dec 15-31; 33(23-24):1727-44. PubMed ID: 740259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adjuvant chemotherapy in the conception of multimodal cancer treatment (author's transl)].
    Tanneberger S
    Arch Geschwulstforsch; 1980; 50(2):160-4. PubMed ID: 7002090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer.
    De Lena M; Zucali R; Viganotti G; Valagussa P; Bonadonna G
    Cancer Chemother Pharmacol; 1978; 1(1):53-9. PubMed ID: 373908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The efficacy of chemotherapy in the treatment of cancer of the breast (author's transl)].
    Zwicker H; Alder W; Engeler V
    Rontgenblatter; 1979 Feb; 32(2):96-8. PubMed ID: 419354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy.
    Valagussa P; Zambetti M; Bonadonna G; Zucali R; Mezzanotte G; Veronesi U
    Breast Cancer Res Treat; 1990 May; 15(3):137-47. PubMed ID: 2372569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination treatment of localised breast cancers with a high risk of metastatic disease. The results of a prospective controlled study (author's transl)].
    Chauvergne J; Durand M; Richaud P; Avril A; Hoerni B; Lagarde C
    J Gynecol Obstet Biol Reprod (Paris); 1981; 10(1):75-85. PubMed ID: 7019300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Induction chemotherapy in high risk breast cancer. Results of a prospective therapeutic study (author's transl)].
    Chauvergne J; Durand M; Hoerni B; Cohen P; Lagarde C
    Bull Cancer; 1979; 66(1):9-16. PubMed ID: 420953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.